Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13144 Neoplasms 10492 Carcinoma, Non-Small-Cell Lung 6878 Prostatic Neoplasms 6276 Colorectal Neoplasms 5950 Lung Neoplasms 5110 Multiple Myeloma 3579 Pancreatic Neoplasms 3564 Leukemia, Myeloid, Acute 3512 Neoplasm Metastasis 3511 Carcinoma, Hepatocellular 3277 Ovarian Neoplasms 3173 Melanoma 3142 Stomach Neoplasms 3058 Lymphoma 2984 Head and Neck Neoplasms 2608 Recurrence 2557 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2500 Leukemia 2362 Colonic Neoplasms 2328 Brain Neoplasms 2317 Lymphoma, Non-Hodgkin 2269 Uterine Cervical Neoplasms 2193 Rectal Neoplasms 2192 Glioblastoma 2018 Leukemia, Lymphocytic, Chronic, B-Cell 1992 Carcinoma, Renal Cell 1915 Squamous Cell Carcinoma of Head and Neck 1880 Lymphoma, Follicular 1851 Esophageal Neoplasms 1801

Interventions

Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vitamin D3 × Clear all

NCT03389659 2018-01-03

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown

Vitamin D3

Data powered by HemOnc (CC BY 4.0) Colophon ⚡